[On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001491:Basophils / Q000187:drug effects*; D002918:Chymotrypsin; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006967:Hypersensitivity / Q000188:drug therapy; D008297:Male; D008407:Mast Cells / Q000187:drug effects*; D008854:Microscopy, Electron; D009539:Nicotinic Acids / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011729:Pyridostigmine Bromide / Q000494:pharmacology; D011817:Rabbits; D012965:Sodium Chloride / Q000494:pharmacology; D013299:Streptodornase and Streptokinase / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D011725:Pyridines; D014665:Vasodilator Agents; D012965:Sodium Chloride; D013299:Streptodornase and Streptokinase; D002918:Chymotrypsin; D011729:Pyridostigmine Bromide
Zur Rolle der basophilen Leukozyten und Mastzellen in Fibrinolyse und Allergie. I. Wirkung von Fibrinolytika und Antifibrinolytika auf den Degranulierungsgrad von basophilen Leukozyten.